文献
J-GLOBAL ID:201702257404703880
整理番号:17A1236527
先天性免疫の新規作動薬,SB-9200は耐性H CV変異体に対する強力な抗ウイルス活性を示す【Powered by NICT】
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants
著者 (11件):
Jones Meleri
(The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK)
,
Cunningham Morven E.
(The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK)
,
Wing Peter
(The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK)
,
DeSilva Sampath
(The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK)
,
Challa Rupa
(Spring Bank Pharmaceuticals, Milford, Massachusetts)
,
Sheri Anjaneyulu
(Spring Bank Pharmaceuticals, Milford, Massachusetts)
,
Padmanabhan Seetharamaiyer
(Spring Bank Pharmaceuticals, Milford, Massachusetts)
,
Iyer Radhakrishnan P.
(Spring Bank Pharmaceuticals, Milford, Massachusetts)
,
Korba Brent E.
(Department of Microbiology & Immunology, Georgetown University Medical Centre, Washington, District of Columbia)
,
Afdhal Nezam
(Department of Microbiology & Immunology, Georgetown University Medical Centre, Washington, District of Columbia)
,
Foster Graham R.
(The Liver Unit, Blizard Institute, Barts Health, Queen Mary University of London, London, UK)
資料名:
Journal of Medical Virology
(Journal of Medical Virology)
巻:
89
号:
9
ページ:
1620-1628
発行年:
2017年
JST資料番号:
E0726B
ISSN:
0146-6615
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)